Lindbrook Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $280K | Buy |
1,249
+244
| +24% | +$54.6K | 0.03% | 325 |
|
|
2024
Q4 | $230K | Hold |
1,005
| – | – | 0.02% | 360 |
|
|
2024
Q3 | $245K | Buy |
1,005
+22
| +2% | +$5.37K | 0.02% | 346 |
|
|
2024
Q2 | $188K | Buy |
983
+35
| +4% | +$6.7K | 0.02% | 375 |
|
|
2024
Q1 | $188K | Buy |
948
+31
| +3% | +$6.14K | 0.02% | 371 |
|
|
2023
Q4 | $158K | Buy |
917
+471
| +106% | +$81K | 0.02% | 392 |
|
|
2023
Q3 | $66K | Buy |
446
+28
| +7% | +$4.14K | 0.01% | 595 |
|
|
2023
Q2 | $91.3K | Sell |
418
-17
| -4% | -$3.72K | 0.01% | 510 |
|
|
2023
Q1 | $95.3K | Buy |
435
+76
| +21% | +$16.6K | 0.01% | 490 |
|
|
2022
Q4 | $74.7K | Sell |
359
-23
| -6% | -$4.79K | 0.01% | 568 |
|
|
2022
Q3 | $83K | Buy |
382
+32
| +9% | +$6.95K | 0.01% | 495 |
|
|
2022
Q2 | $73K | Buy |
350
+41
| +13% | +$8.55K | 0.01% | 534 |
|
|
2022
Q1 | $75K | Buy |
309
+28
| +10% | +$6.8K | 0.01% | 556 |
|
|
2021
Q4 | $73K | Sell |
281
-653
| -70% | -$170K | 0.01% | 596 |
|
|
2021
Q3 | $246K | Buy |
934
+5
| +0.5% | +$1.32K | 0.06% | 126 |
|
|
2021
Q2 | $229K | Hold |
929
| – | – | 0.05% | 148 |
|
|
2021
Q1 | $180K | Buy |
929
+6
| +0.7% | +$1.16K | 0.04% | 168 |
|
|
2020
Q4 | $196K | Buy |
923
+3
| +0.3% | +$637 | 0.05% | 142 |
|
|
2020
Q3 | $158K | Buy |
920
+3
| +0.3% | +$515 | 0.04% | 147 |
|
|
2020
Q2 | $176K | Sell |
917
-18
| -2% | -$3.46K | 0.05% | 134 |
|
|
2020
Q1 | $138K | Buy |
935
+18
| +2% | +$2.66K | 0.05% | 145 |
|
|
2019
Q4 | $142K | Buy |
917
+24
| +3% | +$3.72K | 0.05% | 192 |
|
|
2019
Q3 | $121K | Hold |
893
| – | – | 0.05% | 203 |
|
|
2019
Q2 | $108K | Hold |
893
| – | – | 0.04% | 219 |
|
|
2019
Q1 | $92K | Hold |
893
| – | – | 0.04% | 238 |
|
|
2018
Q4 | $101K | Buy |
+893
| New | +$101K | 0.05% | 198 |
|